Fda Gives Go Ahead For Trial Of Experimental Drug To Prevent Covid 19 Patients From Needing Ventilators
In its trial named Vangard, U.S.-based biopharmaceutical firm PhaseBio will see if a drug called PB1046 is safe and effective in COVID-19 patients who are at high risk of rapidly deteriorating and developing acute respiratory distress syndrome (ARSD). The life-threatening syndrome happens when the lungs fail to provide enough oxygen to the vital organs. Generally, these patients are admitted to intensive care units and hooked up to ventilators. The move comes as scientists around the world race to create the first treatment specifically for COVID-19, the disease caused by the coronavirus....